Checkmate Pharmaceuticals Welcomes Industry Leader Jon Wigginton, M.D. to its Board of Directors

31.01.2022 - CAMBRIDGE, Mass., Jan. 31, 2022 (GLOBE NEWSWIRE) - Checkmate Pharmaceuticals, Inc. (NASDAQ: CMPI) (“Checkmate”), a clinical stage biopharmaceutical company focused on developing its proprietary technology to harness the power of the immune system ... Seite 1

Related Keywords

Michigan ,United States ,Sutro Biopharma ,Bristol Myers Squibb ,Cancer Research ,Oncology For Early Clinical Research ,Society For Immunotherapy Of Cancer ,National Cancer Institute ,Clinical Oncology At Merck Research Laboratories ,Cullinan Oncology Inc ,University Of Michigan ,Senior Advisor ,Cullinan Oncology ,Medical Officer ,Chief Medical Officer ,Therapeutic Area Head ,Early Clinical Research ,Executive Medical Director ,Group Medical Director ,Discovery Medicine Clinical Oncology ,Clinical Oncology ,Merck Research ,Investigational Biologics Section ,